Works matching IS 00099236 AND DT 1999 AND VI 65 AND IP 5

Results: 16

Investigation of terbinafine as a CYP2D6 inhibitor in vivo*.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 465, doi. 10.1016/S0009-9236(99)70065-2
By:
- Abdel-Rahman, Susan M.;
- Gotschall, R. Russell;
- Kauffman, Ralph E.;
- Leeder, J. Steven;
- Kearns, Gregory L.
Publication type:
Article
Pharmacokinetics and pharmacodynamics of SB 209670, an endothelin receptor antagonist: Effects on the regulation of renal vascular tone*.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 473, doi. 10.1016/S0009-9236(99)70066-4
By:
- Freed, Martin I.;
- Wilson, Douglas E.;
- Thompson, Kathleen A.;
- Harris, Robert Z.;
- Ilson, Bernard E.;
- Jorkasky, Diane K.
Publication type:
Article
Thalidomide does not alter estrogen-progesterone hormone single-dose pharmacokinetics*.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 483, doi. 10.1016/S0009-9236(99)70067-6
By:
- Scheffler, Michael R.;
- Colburn, Wayne;
- Kook, Karin A.;
- Thomas, Steve D.
Publication type:
Article
Clinical pharmacokinetics of encapsulated oral 9-aminocamptothecin in plasma and saliva.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 491, doi. 10.1016/S0009-9236(99)70068-8
By:
- de Jonge, Maja J.A.;
- Verweij, Jaap;
- Loos, Walter J.;
- Dallaire, Brian K.;
- Sparreboom, Alex
Publication type:
Article
Quinine disposition in globally malnourished children with cerebral malaria.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 500, doi. 10.1016/S0009-9236(99)70069-X
By:
- Pussard, Eric;
- Barennes, Hubert;
- Daouda, Hamani;
- Clavier, Françoise;
- Sani, Abdoulaye Mahaman;
- Osse, Martin;
- Granic, Gérard;
- Verdier, Françoise
Publication type:
Article
Influence of arteriovenous sampling on remifentanil pharmacokinetics and pharmacodynamics*.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 511, doi. 10.1016/S0009-9236(99)70070-6
By:
- Hermann, David J.;
- Egan, Talmage D.;
- Muir, Keith T.
Publication type:
Article
Impact of genetic polymorphisms of the β2-adrenergic receptor on albuterol bronchodilator pharmacodynamics*.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 519, doi. 10.1016/S0009-9236(99)70071-8
By:
- Lima, John J.;
- Thomason, Donald B.;
- Mohamed, Mohamad H.N.;
- Eberle, Louis V.;
- Self, Timothy H.;
- Johnson, Julie A.
Publication type:
Article
The cytotoxicity of clozapine metabolites: Implications for predicting clozapine-induced agranulocytosis*.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 526, doi. 10.1016/S0009-9236(99)70072-X
By:
- Tschen, Alice C.;
- Rieder, Michael J.;
- Oyewumi, L. Kola;
- Freeman, David J.
Publication type:
Article
Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state*.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 533, doi. 10.1016/S0009-9236(99)70073-1
By:
- Tegeder, Irmgard;
- Lötsch, Jörn;
- Krebs, Sabine;
- Muth-Selbach, Uta;
- Brune, Kay;
- Geisslinger, Gerd
Publication type:
Article
G-Protein-coupled receptor kinase expression in hypertension*.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 545, doi. 10.1016/S0009-9236(99)70074-3
By:
- Gros, Robert;
- Tan, Christopher M.;
- Chorazyczewski, Jozef;
- Kelvin, David J.;
- Benovic, Jeffrey L.;
- Feldman, Ross D.
Publication type:
Article
CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans*.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 552, doi. 10.1016/S0009-9236(99)70075-5
By:
- Furuta, Takahisa;
- Ohashi, Kyoichi;
- Kosuge, Kazuhiro;
- Zhao, Xue-Jun;
- Takashima, Misako;
- Kimura, Masahiko;
- Nishimoto, Masahiko;
- Hanai, Hiroyuki;
- Kaneko, Eizo;
- Ishizaki, Takashi
Publication type:
Article
Relationship between acetylation polymorphism and risk of atopic diseases*.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 562, doi. 10.1016/S0009-9236(99)70076-7
By:
- Gawrońska-Szklarz, Barbara;
- Luszawska-Kutrzeba, Teresa;
- Czaja-Bulsa, Grażyna;
- Kurzawski, Grzegorz
Publication type:
Article
Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 570, doi. 10.1016/S0009-9236(99)70077-9
By:
- Tateishi, Tomonori;
- Chida, Michihiro;
- Ariyoshi, Noritaka;
- Mizorogi, Yoshihiro;
- Kamataki, Tetsuya;
- Kobayashi, Shinichi
Publication type:
Article
Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism*.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 576, doi. 10.1016/S0009-9236(99)70078-0
By:
- Iyer, Lalitha;
- Hall, Diana;
- Das, Soma;
- Mortell, Melissa A.;
- Ramírez, Jacqueline;
- Kim, Sarang;
- Di Rienzo, Anna;
- Ratain, Mark J.
Publication type:
Article
Notes of the American Society for Clinical Pharmacology and Therapeutics.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 586, doi. 10.1016/S0009-9236(99)70079-2
By:
- Jones, Judith K.
Publication type:
Article
Notes of the American Society for Clinical Pharmacology and Therapeutics.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 586, doi. 10.1016/S0009-9236(99)70080-9
Publication type:
Article

Works matching IS 00099236 AND DT 1999 AND VI 65 AND IP 5

Investigation of terbinafine as a CYP2D6 inhibitor in vivo<sup>*</sup>.

Pharmacokinetics and pharmacodynamics of SB 209670, an endothelin receptor antagonist: Effects on the regulation of renal vascular tone<sup>*</sup>.

Thalidomide does not alter estrogen-progesterone hormone single-dose pharmacokinetics<sup>*</sup>.

Clinical pharmacokinetics of encapsulated oral 9-aminocamptothecin in plasma and saliva.

Quinine disposition in globally malnourished children with cerebral malaria.

Influence of arteriovenous sampling on remifentanil pharmacokinetics and pharmacodynamics<sup>*</sup>.

Impact of genetic polymorphisms of the β<sub>2</sub>-adrenergic receptor on albuterol bronchodilator pharmacodynamics<sup>*</sup>.

The cytotoxicity of clozapine metabolites: Implications for predicting clozapine-induced agranulocytosis<sup>*</sup>.

Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state<sup>*</sup>.

G-Protein-coupled receptor kinase expression in hypertension<sup>*</sup>.

CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans<sup>*</sup>.

Relationship between acetylation polymorphism and risk of atopic diseases<sup>*</sup>.

Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population.

Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism<sup>*</sup>.

Notes of the American Society for Clinical Pharmacology and Therapeutics.

Notes of the American Society for Clinical Pharmacology and Therapeutics.